Sarossa Capital

Sarissa Capital Management is a prominent healthcare-focused activist investment firm that specializes in the biotechnology and pharmaceutical industries. Founded by Dr. Alexander Denner, the firm identifies undervalued healthcare companies and engages actively with their management teams and boards to enhance shareholder value. Sarissa is well-known for its strategic interventions and proxy contests at major life sciences companies, including Amarin, Biogen, and Ironwood Pharmaceuticals. The firm leverages its deep industry expertise to influence corporate strategy, capital allocation, and research and development priorities within its portfolio. By seeking board representation and advocating for operational changes, Sarissa aims to unlock the intrinsic value of innovative medical technologies and therapies.